Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -32.56 Million EUR | -5.85% |
| 2022 | -30.76 Million EUR | -30.27% |
| 2021 | -23.61 Million EUR | -23.6% |
| 2020 | -19.1 Million EUR | -27.57% |
| 2019 | -14.97 Million EUR | -7.11% |
| 2018 | -13.98 Million EUR | -70.0% |
| 2017 | -8.22 Million EUR | 41.14% |
| 2016 | -13.97 Million EUR | -20.92% |
| 2015 | -11.55 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -5.53 Million EUR | 0.0% |
| 2024 Q1 | -5.53 Million EUR | 31.18% |
| 2023 Q1 | -8.23 Million EUR | 48.25% |
| 2023 Q3 | -8.04 Million EUR | 51.11% |
| 2023 Q4 | -8.04 Million EUR | 0.0% |
| 2023 Q2 | -16.46 Million EUR | -100.0% |
| 2023 FY | -32.56 Million EUR | -5.85% |
| 2022 Q2 | -14.85 Million EUR | -100.0% |
| 2022 Q4 | -15.9 Million EUR | -100.0% |
| 2022 FY | -30.76 Million EUR | -30.27% |
| 2022 Q1 | -7.42 Million EUR | 36.65% |
| 2022 Q3 | -7.95 Million EUR | 46.46% |
| 2021 Q1 | -5.94 Million EUR | 37.76% |
| 2021 FY | -23.61 Million EUR | -23.6% |
| 2021 Q4 | -11.72 Million EUR | -100.0% |
| 2021 Q3 | -5.86 Million EUR | 50.69% |
| 2021 Q2 | -11.89 Million EUR | -100.0% |
| 2020 Q4 | -9.55 Million EUR | -100.0% |
| 2020 Q3 | -4.77 Million EUR | 50.01% |
| 2020 Q1 | -4.77 Million EUR | 37.76% |
| 2020 Q2 | -9.55 Million EUR | -100.0% |
| 2020 FY | -19.1 Million EUR | -27.57% |
| 2019 FY | -14.97 Million EUR | -7.11% |
| 2019 Q4 | -7.67 Million EUR | -100.0% |
| 2019 Q3 | -3.83 Million EUR | 47.46% |
| 2019 Q2 | -7.3 Million EUR | -100.0% |
| 2019 Q1 | -3.65 Million EUR | 31.74% |
| 2018 Q4 | -5.34 Million EUR | -33.78% |
| 2018 Q2 | -2.52 Million EUR | 0.0% |
| 2018 FY | -13.98 Million EUR | -70.0% |
| 2018 Q1 | -2.52 Million EUR | -41.01% |
| 2018 Q3 | -3.99 Million EUR | -58.52% |
| 2017 Q4 | -1.78 Million EUR | 16.83% |
| 2017 Q3 | -2.15 Million EUR | 0.0% |
| 2017 FY | -8.22 Million EUR | 41.14% |
| 2016 FY | -13.97 Million EUR | -20.92% |
| 2015 FY | -11.55 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | -108.034% |
| Bluelinea Société Anonyme | -1.62 Million EUR | -1910.097% |
| Carmat SA | -53.86 Million EUR | 39.55% |
| Diagnostic Medical Systems S.A. | -4.94 Million EUR | -558.382% |
| Euromedis Groupe | 13.11 Million EUR | 348.381% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | 773.497% |
| Ikonisys S.A. | -2.26 Million EUR | -1336.008% |
| Implanet S.A. | -6.67 Million EUR | -387.771% |
| Median Technologies SA | -22.98 Million EUR | -41.692% |
| SpineGuard SA | -4.18 Million EUR | -678.397% |
| Theraclion SA | -3.67 Million EUR | -786.082% |
| Euroapi S.A. | -189.7 Million EUR | 82.834% |
| Guerbet SA | 23.86 Million EUR | 236.443% |
| Ion Beam Applications SA | -9.11 Million EUR | -257.449% |
| Koninklijke Philips N.V. | -466 Million EUR | 93.012% |